Papers: 10.1371/journal.pone.0233116

https://doi.org/10.1371/journal.pone.0233116

DLX1008 (brolucizumab), a single-chain anti-VEGF-A antibody fragment with low picomolar affinity, leads to tumor involution in an in vivo model of Kaposi Sarcoma

Cited by: 8
Author(s): Anthony Eason, Sang-Hoon Sin, Mohsin Shah, Hong Yuan, Douglas J. Phillips, Miriam Droste, Abdijapar Shamshiev, Dirk P. Dittmer
Published: about 5 years ago

Software Mentions 4